Articles and Editorials|

SHL shares insights into developing digital solutions for drug delivery systems

B Home Page Bg 800x580

Advances in technology are driving a proliferation of smart connected devices that can store and transmit valuable usage data. In the area of drug delivery, the data can be used to help patient adherence and facilitate communication from patient to health care provider and further.

Combining internal knowledge and experience with active partnerships, SHL has launched a number of initiatives in the digital space for drug delivery systems. The company recently shared its insights in the article “Not Just another Gadget: Insights into Developing Digital Solutions That Work,” which was published in the June 2017 issue of OnDrugDelivery Magazine.

Emphasizing the patient-centric approach to developing connected devices, the article explores the development of digital health by asking the following key questions:

  • Will connected devices be accepted in the real world?
  • Where do we start?
  • How do we create additional value?
  • Who will benefit?

In addressing the questions, the article notes that a connected device should not be treated as “another gadget that will entertain the user for a few months and then be forgotten.” Rather, digital solutions for drug delivery solutions need to be developed with a thoughtful and weighted approach that is aimed at providing both short- and long-term benefits for patients and stakeholders alike.

Read the article in full HERE, or online at ONDrugDelivery.

About SHL Medical

As a world-leading solutions provider of advanced drug delivery systems, SHL Medical is the partner of choice for many leading pharma and biotech companies. Driven by our company purpose – Enabling Patients’ Independence – we offer patient-centric solutions for the design, development, and manufacturing of autoinjectors, pen injectors, as well as innovative specialty delivery systems for large-volume and high-viscosity formulations. We also offer final assembly, labeling, and packaging solutions for our drug delivery systems.  ​

In response to the rising trend in home therapy, SHL has increased developmental work in the digital healthcare sector to help improve the drug delivery ecosystem

Located across Switzerland, Taiwan, Sweden, and the US, our global team of experts collaborate seamlessly as one team in utilizing our comprehensive in-house manufacturing capabilities. Our solutions offer customization and optimization for each project while proactively weaving sustainability-driven measures into our designs and processes to contribute to a cleaner earth.​

For additional information, visit www.shl-medical.com

Media contact: info@shl-medical.com

Share:

Related News

In the Pre-filled Syringes and Injection Devices Issue of ONdrug Delivery Magazine, published ahead of the 2023 PDA Universe of Pre-filled Syringes and Injection Devices Conference, SHL Medical’s Edwin Hendrawan, Yi-Chi Lu, and Christian Walter detail how simulation technologies have been crucial in continuously strengthening the company’s global manufacturing operations and expansion plans.